Cullen/Frost Bankers, Inc. Royalty Pharma PLC Transaction History
Cullen/Frost Bankers, Inc.
- $7.02 Billion
- Q1 2025
A detailed history of Cullen/Frost Bankers, Inc. transactions in Royalty Pharma PLC stock. As of the latest transaction made, Cullen/Frost Bankers, Inc. holds 247,963 shares of RPRX stock, worth $8.64 Million. This represents 0.11% of its overall portfolio holdings.
Number of Shares
247,963
Previous 60
413171.67%
Holding current value
$8.64 Million
Previous $1,000
771800.0%
% of portfolio
0.11%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding RPRX
# of Institutions
484Shares Held
283MCall Options Held
2.51MPut Options Held
941K-
Morgan Stanley New York, NY41MShares$1.43 Billion0.09% of portfolio
-
Vanguard Group Inc Valley Forge, PA36.7MShares$1.28 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY23MShares$802 Million0.01% of portfolio
-
Baillie Gifford & CO13.4MShares$467 Million0.38% of portfolio
-
Swedbank Ab Stockholm, V712.2MShares$424 Million0.39% of portfolio
About Royalty Pharma plc
- Ticker RPRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 437,139,008
- Market Cap $15.2B
- Description
- Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...